The Bristol Myers Squibb 2021 Golden Ticket Contest is a competition for the award of two Golden Tickets, which covers the cost of one 6-ft lab bench and one resident scientist fee for one year for a promising life science start-up.
A Brazilian mining company is seeking startups to transform and increase production chain.
Seeking several startups to participate in the West Coast / Silicon Valley Startup Showcase on October 20.
Exploring opportunities in healthcare and related applications by leveraging cutting edge technologies
The MIT Bangkok Symposium is the first regional conference in Thailand organized by the MIT Industrial Liaison Program (ILP), in cooperation with Bangkok Bank, Ltd. The symposium will bring together industry, academic, and investment leaders from the Healthcare and BioTech ecosystem at MIT and across Southeast Asia to Bangkok, Thailand. Attendees will benefit from distinguished speakers and panelists, including industry luminaries, pioneers, investors, and world-class researchers, with whom they can interact during networking sessions. HealthTech and BioTech entrepreneurs from the MIT Startup Exchange will exhibit their transformative solutions in the Symposium and be open to discuss potential collaboration with attendees.
DFactory is looking for startups aiming to expand in Europe and working on sensors, AI, blockchain, 3D printing, robotics, IoT, cybersecurity, and advanced manufacturing.
MIT Startup Exchange, Center for Real Estate and MIT.nano are looking for 2 to 4 startup speakers for the MIT Build.nano Conference, April 13.
Safran Explore is looking for the technologies that will shape the future of aerospace, defense, and space. Five challenges are currently open until September 30. Select startups will access technical, business & industrial support, access test facilities, R&D teams, fast-track industrialization and more.
The MIT Industrial Liaison Programand MIT Startup Exchange are organizing a forum on the next generation of networks, taking place on October 28, 2025, in Cambridge, MA. We are seeking 4–6 innovative startups to present and exhibit. This forum will examine key technologies for our connected future – from integrated photonics and advanced microelectronics, through AI for networks and networks for AI, to software-defined networks and satellite communications.
AI Driven Bloodless Blood Tests Sean (Shunsuke) Matsuoka, Co-Founder & COO, GPx GPx: https://gpx.ai/
In an aging society, the number of heart failure patients is increasing, making the prevention of readmissions and reduction of medical costs critical issues. Remote monitoring using invasive implantable devices has proven effective in reducing heart failure readmissions, but its use remains limited.
To address this, GPx has developed an algorithm that non-invasively predicts signs of heart failure exacerbation. This algorithm was created using clinical trial data from monitoring 245 heart failure patients over 6 months to a year at eight facilities, including the Mayo Clinic in the U.S. The algorithm links digital biomarker data with vital blood tests (NT-proBNP and creatinine) to achieve high-precision prediction and early medical intervention.
Additionally, with a grant of 1.2 billion yen provided through AMED, we are collaborating with the National Cerebral and Cardiovascular Center (Dr. Chisato Izumi) to conduct a clinical trial involving 400 patients starting April 2025. The trial will be conducted at the National Cerebral and Cardiovascular Center, Kyoto University, Kobe University, and Kochi University.
Furthermore, at this year's MIT Japan Conference, we will unveil a groundbreaking point-of-care (POC) potassium testing device for the first time. At the conference, we aim to explore the feasibility of applying our technology to other conditions (such as kidney failure, pulmonary arterial hypertension, and cardio-oncology) and to assess the potential for providing algorithm-based services for heart failure patients within Japan.